explore -WSS

explore

author：Wikipedia 2025-09-29 09:29:52 - browse：665

BARCELONA, Spain — Some of the patients waiting in the oncology ward of a hospital here, with its green-tiled floor and white walls, had arrived for a newfangled remedy for blood cancers, what’s known as a CAR-T therapy.

The patients were not here for one of the brand-name medicines — a Kymriah or Yescarta — that have shown the power of these cell-based approaches and helped reap their makers hundreds of millions of dollars. Rather, they would be receiving a CAR-T brewed up right here at Hospital Clínic de Barcelona.

Under a special European policy, the CAR-T developed by the hospital’s experts had won regulatory approval in Spain and was reimbursed by the national health system like other authorized medications. The therapy provided another option for patients, all at a price of 89,000 euros ($97,000), roughly a third of the list prices of the CAR-T products from biopharma companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

entertainment

WSS

A double vaccine crisis is endangering millions of children

How to pay for weight loss drugs and save Medicare

Fetal surgery at risk from Dobbs and new abortion restrictions

Why an extreme heat and wildfire smoke combination can be so dangerous

Russian special forces kill a gunman who broke into a private house near Moscow

Artificial intelligence advances fuel industry trying to preserve loved ones after death

Wikipedia

explore

knowledge

Apple is now the first public company to be valued at $3 trillion

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

In Memoriam: Notable people who died in 2023

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Hepatitis C has a cure — but many Americans still lack access to it

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Virginia high school admissions case could be legal follow

Cigna, Humana reportedly in talks to merge

Medical leaders decry Supreme Court decision on affirmative action

Cigna, Humana reportedly in talks to merge

focus

Cigna, Humana reportedly in talks to merge

What don’t we know about an Alzheimer’s drug side effect?

Pediatric cancer treatments threatened by a new FDA policy

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

White House launches permanent pandemic office

Elizabeth Warren probes abortion access

explore

entertainment

knowledge

focus